Cargando…

Evaluation of Imaging Windows for Tau PET Imaging Using (18)F-PI2620 in Cognitively Normal Individuals, Mild Cognitive Impairment, and Alzheimer’s Disease Patients

BACKGROUND: The study aimed to evaluate the appropriate uptake-timing in cognitively normal individuals, mild cognitive impairment (MCI), and Alzheimer’s disease (AD) patients, using (18)F-PI 2620 dynamic PET acquisition. METHODS: Thirty-four MCI patients, 6 AD patients, and 24 cognitively normal in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chotipanich, Chanisa, Nivorn, Monchaya, Kunawudhi, Anchisa, Promteangtrong, Chetsadaporn, Boonkawin, Natphimol, Jantarato, Attapon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466905/ https://www.ncbi.nlm.nih.gov/pubmed/32862780 http://dx.doi.org/10.1177/1536012120947582

Ejemplares similares

The Evaluation of Tau Deposition with [(18)F]PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer's Disease
por: Jantarato, Attapon, et al.
Publicado: (2021)

Analysis of amyloid and tau deposition in Alzheimer's disease using (11)C-Pittsburgh compound B and (18)F-THK 5351 positron emission tomography imaging
por: Chanisa, Chotipanich, et al.
Publicado: (2020)

Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [(18)F]F-FDG PET/CT in Patients with Liver Malignancies
por: Siripongsatian, Dheeratama, et al.
Publicado: (2022)

(11)C-Pittsburgh compound B and (18)F-THK 5351 positron emission tomography brain imaging in cognitively normal individuals
por: Chotipanich, Chanisa, et al.
Publicado: (2020)

A case report of hyperfunctioning metastatic thyroid cancer and rare I-131 avid liver metastasis
por: Kunawudhi, Anchisa, et al.
Publicado: (2016)

Abnormality Pattern of F-18 FDG PET Whole Body with Functional MRI Brain in Post-Acute COVID-19
por: Kiatkittikul, Peerapon, et al.
Publicado: (2022)

(11)C-Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma: A Comparative Analysis
por: Chotipanich, Chanisa, et al.
Publicado: (2015)

Alterations of regional cerebral glucose metabolism using(18)F-fluorodeoxyglucose positron-emission tomography/computed tomography and electroencephalography analysis during mindfulness breathing in Anapanasati meditation: A preliminary analysis
por: Chotipanich, Chanisa, et al.
Publicado: (2020)

Feasibility of short imaging protocols for [(18)F]PI-2620 tau-PET in progressive supranuclear palsy
por: Song, Mengmeng, et al.
Publicado: (2021)

Early-phase [(18)F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury
por: Beyer, Leonie, et al.
Publicado: (2020)

Case Report: [(18)F]PI2620 as a Tau Imaging Agent in Posterior Cortical Atrophy
por: Kong, Yu, et al.
Publicado: (2020)

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
por: Chandra, Avinash, et al.
Publicado: (2019)

Multicenter (18)F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease
por: Rullmann, Michael, et al.
Publicado: (2022)

Findings of (18)F‐PI‐2620 tau PET imaging in patients with Alzheimer’s disease and healthy controls in relation to the plasma P‐tau181 levels in a Japanese sample
por: Bun, Shogyoku, et al.
Publicado: (2022)

Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET
por: Promteangtrong, Chetsadaporn, et al.
Publicado: (2015)

Binding characteristics of [(18)F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET
por: Song, Mengmeng, et al.
Publicado: (2021)

Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [(18)F]-PI-2620 tau-PET signal
por: Schönecker, Sonja, et al.
Publicado: (2023)

Evaluation of tau deposition using (18)F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study
por: Bullich, Santiago, et al.
Publicado: (2022)

Multimodality Imaging Approach in Alzheimer disease. Part I: Structural MRI, Functional MRI, Diffusion Tensor Imaging and Magnetization Transfer Imaging
por: Promteangtrong, Chetsadaporn, et al.
Publicado: (2015)

Identification of Heterogeneous Subtypes of Mild Cognitive Impairment Using Cluster Analyses Based on PET Imaging of Tau and Astrogliosis
por: Lee, Hyun Jeong, et al.
Publicado: (2021)

Assessment of perfusion deficit with early phases of [(18)F]PI-2620 tau-PET versus [(18)F]flutemetamol-amyloid-PET recordings
por: Völter, Friederike, et al.
Publicado: (2022)

Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
por: Kroth, Heiko, et al.
Publicado: (2019)

Comparison Between Postprocessing Software and Repeated Scanning to Eliminate Subdiaphragmatic Activity in Myocardial Perfusion Scintigraphy
por: Theerakulpisut, Daris, et al.
Publicado: (2016)

Quantitative (18)F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients
por: Zhao, Qian, et al.
Publicado: (2019)

Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions
por: Heidari, Pedram, et al.
Publicado: (2018)

Additive value of [(18)F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
por: Katzdobler, Sabrina, et al.
Publicado: (2022)

Evaluation of [(18)F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies
por: Tezuka, Toshiki, et al.
Publicado: (2021)

Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer’s disease, corticobasal degeneration and progressive supranuclear palsy brains
por: Malarte, Mona-Lisa, et al.
Publicado: (2022)

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment
por: Jiao, Fangyang, et al.
Publicado: (2023)

[(18)F]THK5351 PET Imaging in Patients with Mild Cognitive Impairment
por: Jeong, Hye Jin, et al.
Publicado: (2020)

Novel brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer’s disease and mild cognitive impairment
por: Huang, Jie
Publicado: (2022)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
por: Rubinski, Anna, et al.
Publicado: (2020)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

Test on the shaper cable-timed CERN-NP type N 2620
por: Bianchetti, G, et al.
Publicado: (1968)

Further Evidence That the CFTR Variant c.2620-6T>C Is Benign
por: Wallerstein, Violet I., et al.
Publicado: (2017)

Effects of Cognitive Training in Mild Cognitive Impairmentmeasured by Resting State Functional Imaging
por: Kim, Seungho, et al.
Publicado: (2020)

Alzheimer’s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline
por: Bucci, Marco, et al.
Publicado: (2021)

Brain imaging of mild cognitive impairment and Alzheimer's disease
por: Yin, Changhao, et al.
Publicado: (2013)

Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease
por: Sasikumar, Sanskriti, et al.
Publicado: (2020)

Quality Assessment of Research Articles in Nuclear Medicine Using STARD and QUADAS-2 Tools
por: Roysri, Krisana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_98r4jfqpob5m219obtff1mjbj1